Skip to main content

Eli Lilly and Company Trulicity revenue

  • LLY · NYSE
  • Pharmaceuticals
  • S&P 500
$1443.50+1.14%Close 13 Nov 2026 · Market value $1.36T

Trulicity revenue at Eli Lilly and Company came to $601.0M for the quarter to 30 Sep 2026, down 15.0% from a year earlier.

As Eli Lilly and Company reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 29 Oct 2026.

By quarter

$1.3BDec 2023$1.1BMar 2024$876.7MJun 2024$935.3MSep 2024$799.8MDec 2024$771.0MMar 2025$744.0MJun 2025$707.0MSep 2025$693.0MDec 2025$600.0MMar 2026$908.0MJun 2026$601.0MSep 2026
Eli Lilly and Company Trulicity revenue, every reported period
Period endingTrulicity revenueChange on a yearFiled
30 Sep 2026$601.0Mdown 15.0%29 Oct 2026
30 Jun 2026$908.0Mup 22.0%5 Aug 2026
31 Mar 2026$600.0Mdown 22.2%30 Apr 2026
31 Dec 2025$693.0Mdown 13.4%12 Feb 2026
30 Sep 2025$707.0Mdown 24.4%30 Oct 2025
30 Jun 2025$744.0Mdown 15.1%7 Aug 2025
31 Mar 2025$771.0Mdown 28.7%1 May 2025
31 Dec 2024$799.8Mdown 36.3%19 Feb 2025
30 Sep 2024$935.3Mdown 25.7%30 Oct 2024
30 Jun 2024$876.7Mdown 36.1%8 Aug 2024
31 Mar 2024$1.1Bdown 30.1%30 Apr 2024
31 Dec 2023$1.3Bdown 17.7%21 Feb 2024
30 Sep 2023$1.3Bdown 11.2%2 Nov 2023
30 Jun 2023$1.4Bdown 4.1%8 Aug 2023
31 Mar 2023$1.5Bup 17.8%27 Apr 2023
31 Dec 2022$1.5Bup 5.4%22 Feb 2023
30 Sep 2022$1.4Bup 18.1%1 Nov 2022
30 Jun 2022$1.4Bup 24.6%4 Aug 2022
31 Mar 2022$1.3Bup 17.6%29 Apr 2022
31 Dec 2021$1.4Bup 24.6%23 Feb 2022
30 Sep 2021$1.2Bup 51.8%27 Oct 2021
30 Jun 2021$1.1Bup 20.5%3 Aug 2021
31 Mar 2021$1.1Bup 20.2%30 Apr 2021
31 Dec 2020$1.2Bup 23.4%17 Feb 2021
30 Sep 2020$791.2Mup 4.7%28 Oct 2020
30 Jun 2020$952.5Mup 20.2%31 Jul 2020
31 Mar 2020$929.5Mup 39.6%1 May 2020
31 Dec 2019$942.0Mup 29.2%19 Feb 2020
30 Sep 2019$755.5Mup 17.0%25 Oct 2019
30 Jun 2019$792.1Mup 29.3%2 Aug 2019
31 Mar 2019$665.6Mup 26.0%2 May 2019
31 Dec 2018$729.3M—19 Feb 2019
30 Sep 2018$645.9M—6 Nov 2018
30 Jun 2018$612.4M—25 Jul 2018
31 Mar 2018$528.2M—27 Apr 2018

Definition

Revenue from this part of the business, as the company names and reports it in its results. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.

Other operating KPIs of Eli Lilly and Company: Cardiometabolic Health revenue · Zepbound revenue · Mounjaro revenue · Oncology revenue · Verzenio revenue · Immunology revenue · Jardiance revenue · Taltz revenue · Neuroscience revenue · United States revenue · Outside U.S. revenue · Europe revenue · Rest of world revenue · China revenue · Japan revenue · financial statements

Every KPI and segment of LLY, in the terminal.

Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.